Dergiler / Annals of Medical Research / 2019 / Cilt: 26 - Sayı: 7

The effective factors on our early and late results, recurrence and survival in differential thyroid cancers: “An analysis of 184 patients”

Sayfa
1351–1357
DOI
—

Abstract

Aim: The purpose of the study was to investigate the effective prognostic factors on recurrence and mortality in patients withdifferential thyroid cancer.Material and Methods: The effects of various parameters of demographic characteristics, the admission symptoms, physicalexamination, laboratory findings, pathological examination, and surgical method of 184 patients, who underwent surgery due todifferential thyroid cancer between January 1986 and December 2009 in 4th General Surgical Clinic of Ankara Numune Trainingand Research Hospital, on prognosis were examined. The information of the patients was obtained from automation system ofthe hospital and Thyroid Cancer Information and Follow-Up Form of 4th General Surgical Clinic of Ankara Numune Training andResearch Hospital.Results: The sample group consisted of 172 papillary cancer patients and 12 follicular cancer patients. The mean age of the patientswas 45.4 years (15-78). There were 159 (86.4%) female patients and 25 (13.6%) male patients. The mean follow-up period of 161(87.5%) patients, who were followed up regularly, was 73.26 months (1-231). The mean recurrence period was 77.66 months (1-150).Mortality was observed in eight (4.3%) patients during their follow-up period. The mean life expectancy of those who died was 66.87months (1-150 months).*Single variable analysis revealed that the T stage and pathologic final stage were effective on recurrence. Painful nodules andpalpable lymph nodes in the neck and the papillary histological malignant subtype variant, as well as the presence of vascular andadjacent organ invasion, multicentricity, T stage, the lymph nodes, distant metastasis, and the clinical stage during the admissionwere identified to be effective on mortality.Conclusion: The risk of recurrence is high in DTC patients with high T stage and advanced pathologic stage. The rate of survival ofthose with multicentric tumors and advanced pathologic stage is low. Therefore, it is important for patients to be followed up closelywithin a postoperative multidisciplinary context.